[go: up one dir, main page]

GB1249558A - Process for the preparation of size-controlled colloidal iron sols and their stabilized solutions - Google Patents

Process for the preparation of size-controlled colloidal iron sols and their stabilized solutions

Info

Publication number
GB1249558A
GB1249558A GB4129269A GB4129269A GB1249558A GB 1249558 A GB1249558 A GB 1249558A GB 4129269 A GB4129269 A GB 4129269A GB 4129269 A GB4129269 A GB 4129269A GB 1249558 A GB1249558 A GB 1249558A
Authority
GB
United Kingdom
Prior art keywords
ferric
salt
sols
preparation
size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4129269A
Inventor
George Curtis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Priority to GB4129269A priority Critical patent/GB1249558A/en
Publication of GB1249558A publication Critical patent/GB1249558A/en
Expired legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0004Preparation of sols
    • B01J13/0008Sols of inorganic materials in water
    • B01J13/0017Sols of inorganic materials in water by extraction of ions from aqueous solutions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0004Preparation of sols
    • B01J13/0047Preparation of sols containing a metal oxide
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G49/00Compounds of iron
    • C01G49/02Oxides; Hydroxides
    • C01G49/06Ferric oxide [Fe2O3]
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/60Particles characterised by their size
    • C01P2004/64Nanometer sized, i.e. from 1-100 nanometer
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/10Solid density
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/22Rheological behaviour as dispersion, e.g. viscosity, sedimentation stability

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Materials Engineering (AREA)
  • General Physics & Mathematics (AREA)
  • Composite Materials (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

1,249,558. Ferric hydroxide sols. AMERICAN CYANAMID CO. 19 Aug., 1969, No. 41292/69. Heading ClA. [Also in Division A5] Ferric hydroxide sols for intramuscular injection, containing at least 1% Fe and having a viscosity not greater than 30 centistokes, are prepared by reacting an aq. solution of a ferric salt (containing 11-40% of the Fe required in the product) with sufficient weak base ionexchange resin in the OH- form to exchange all the anions of the salt, continuing the reaction until the pH is from 2-4, filtering, adding more ferric salt and resin and maintaining the pH at from 1À6-4, filtering again and adding yellow potato starch dextrin solution having an intrinsic viscosity of from 0À06-0À16 such that the ratio of dextrin : Fe is from 1À3 : 1 to 3À2 : 1, adjusting the pH to from 6 to 8, and adjusting the water content if necessary. The preferred iron salt is ferric chloride hexahydrate and the preferred product should contain about 10% Fe.
GB4129269A 1969-08-19 1969-08-19 Process for the preparation of size-controlled colloidal iron sols and their stabilized solutions Expired GB1249558A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB4129269A GB1249558A (en) 1969-08-19 1969-08-19 Process for the preparation of size-controlled colloidal iron sols and their stabilized solutions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4129269A GB1249558A (en) 1969-08-19 1969-08-19 Process for the preparation of size-controlled colloidal iron sols and their stabilized solutions

Publications (1)

Publication Number Publication Date
GB1249558A true GB1249558A (en) 1971-10-13

Family

ID=10419016

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4129269A Expired GB1249558A (en) 1969-08-19 1969-08-19 Process for the preparation of size-controlled colloidal iron sols and their stabilized solutions

Country Status (1)

Country Link
GB (1) GB1249558A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0428389A2 (en) * 1989-11-13 1991-05-22 Sakai Chemical Industry Co., Ltd., Process for producing metal hydroxide sol
US5895653A (en) * 1995-03-27 1999-04-20 Tempo G Adjuvant based on colloidal iron compounds
WO2008073925A2 (en) * 2006-12-12 2008-06-19 Honda Motor Co., Ltd. Preparation of iron or iron oxide nanoparticles
US8808759B1 (en) 2013-09-25 2014-08-19 Chattem, Inc Stabilized colloidal preparations, pre-mix and process for preparing skin care compositions, improved skin care composition, method for treating the skin
US10624855B2 (en) 2013-11-27 2020-04-21 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceutical composition, comprising phosphate binder particles
US10682376B2 (en) 2007-11-16 2020-06-16 Vifor Fresenius Medical Care Renal Pharma Ltd Pharmaceutical compositions

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0428389A2 (en) * 1989-11-13 1991-05-22 Sakai Chemical Industry Co., Ltd., Process for producing metal hydroxide sol
EP0428389A3 (en) * 1989-11-13 1992-09-09 Sakai Chemical Industry Co., Ltd., Process for producing metal hydroxide sol
US5895653A (en) * 1995-03-27 1999-04-20 Tempo G Adjuvant based on colloidal iron compounds
WO2008073925A2 (en) * 2006-12-12 2008-06-19 Honda Motor Co., Ltd. Preparation of iron or iron oxide nanoparticles
WO2008073925A3 (en) * 2006-12-12 2008-08-28 Honda Motor Co Ltd Preparation of iron or iron oxide nanoparticles
US7985398B2 (en) 2006-12-12 2011-07-26 Honda Motor Co., Ltd. Preparation of iron or iron oxide nanoparticles
US10780113B2 (en) 2007-11-16 2020-09-22 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceutical compositions
US11013762B1 (en) 2007-11-16 2021-05-25 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceutical compositions
US10682376B2 (en) 2007-11-16 2020-06-16 Vifor Fresenius Medical Care Renal Pharma Ltd Pharmaceutical compositions
US10695367B2 (en) 2007-11-16 2020-06-30 Vifor Fresenius Medical Care Renal Pharma Ltd Pharmaceutical compositions
US11013761B1 (en) 2007-11-16 2021-05-25 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceutical compositions
US10925897B2 (en) 2007-11-16 2021-02-23 Vifor Fresenius Medical Care Renal Pharma Ltd Pharmaceutical compositions
US10925896B2 (en) 2007-11-16 2021-02-23 Vifor Fresenius Medical Care Renal Pharma Ltd Pharmaceutical compositions
US10933090B2 (en) 2007-11-16 2021-03-02 Vifor Fresenius Medical Care Renal Pharma Ltd Pharmaceutical compositions
US8808759B1 (en) 2013-09-25 2014-08-19 Chattem, Inc Stabilized colloidal preparations, pre-mix and process for preparing skin care compositions, improved skin care composition, method for treating the skin
US10624855B2 (en) 2013-11-27 2020-04-21 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceutical composition, comprising phosphate binder particles
US11234938B2 (en) 2013-11-27 2022-02-01 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceutical composition, comprising phosphate binder particles
US11234937B2 (en) 2013-11-27 2022-02-01 Vifor Fresenius Medical Care Renal Pharma Ltd. Method of manufacturing pharmaceutical compositions
US11446251B2 (en) 2013-11-27 2022-09-20 Vifor Fresenius Medical Care Renal Pharma Ltd. Method of manufacturing pharmaceutical compositions
US11446252B2 (en) 2013-11-27 2022-09-20 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceutical composition, comprising phosphate binder particles

Similar Documents

Publication Publication Date Title
GB1486890A (en) Catalysts and their use in hydrogenation
GB1249558A (en) Process for the preparation of size-controlled colloidal iron sols and their stabilized solutions
GB1484110A (en) Catalyst recovery process
IE42186L (en) Metal amide monomeric and polymeric complexes
GB1462943A (en) Process for continuous production of aqueous basic aluminium salt solution
GB1129980A (en) Alumina agglomerates
GB1350768A (en) Precipitation of copper
GB1520109A (en) Process for production of solution of a basic aluminium salt and its use in water treatment
GB1320701A (en) Process for manufacturing magnesium hydroxide
IE43720L (en) Preparation of concentrated solutions of hydrazine hydrate
GB1183449A (en)
GB1528117A (en) Process for the preparation of a hydroxylamine salt and the pretreatment of catalyst compositions used therein
GB1125706A (en) Process for the production of hexamethylene diamine
GB1483210A (en) Process for purifying water by precipitating the heavy metal ion complexes of polycarboxylates
GB1245169A (en) Iron oxide process
GB1332006A (en) Method of manufacturing alpha-strontium acid phosphate
GB1451351A (en) Process for preparing salts of alkanoic acids
GB939104A (en) Improvements in or relating to the manufacture of phosphors
GB1259381A (en)
US3681054A (en) Method for selective reduction of a pair of metal salts closely adjacent in the electromotive series from solution in the form of metal powder with the aid of a reducing gas
GB1361354A (en) Nickel recovery process
GB1471162A (en) Operation of a two-phase reactor
GB1244387A (en) Continuous production of tetrachloro-o-phthalonitrile
GB1392077A (en) Production of cyanogen chloride
GB1257607A (en)